These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 34032966)

  • 1. Knockdown of ANXA10 inhibits proliferation and promotes apoptosis of papillary thyroid carcinoma cells by down-regulating TSG101 thereby inactivating the MAPK/ERK signaling pathway.
    Wei T; Zhu X
    J Bioenerg Biomembr; 2021 Aug; 53(4):429-440. PubMed ID: 34032966
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Semaphorin 3D inhibits proliferation and migration of papillary thyroid carcinoma by regulating MAPK/ERK signaling pathway.
    Hai R; You Q; Wu F; Qiu G; Yang Q; Shu L; Xie L; Zhou X
    Mol Biol Rep; 2022 May; 49(5):3793-3802. PubMed ID: 35190928
    [TBL] [Abstract][Full Text] [Related]  

  • 3. microRNA-124-3p inhibits tumourigenesis by targeting mitogen-activated protein kinase 4 in papillary thyroid carcinoma.
    Sun Y; Zhang L; Zhang S
    Cell Biochem Funct; 2020 Dec; 38(8):1017-1024. PubMed ID: 32495394
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Down-regulation of TSG101 by small interfering RNA inhibits the proliferation of breast cancer cells through the MAPK/ERK signal pathway.
    Zhang Y; Song M; Cui ZS; Li CY; Xue XX; Yu M; Lu Y; Zhang SY; Wang EH; Wen YY
    Histol Histopathol; 2011 Jan; 26(1):87-94. PubMed ID: 21117030
    [TBL] [Abstract][Full Text] [Related]  

  • 5. DPP4 gene silencing inhibits proliferation and epithelial-mesenchymal transition of papillary thyroid carcinoma cells through suppression of the MAPK pathway.
    Hu X; Chen S; Xie C; Li Z; Wu Z; You Z
    J Endocrinol Invest; 2021 Aug; 44(8):1609-1623. PubMed ID: 33387351
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MiR-20b Displays Tumor-Suppressor Functions in Papillary Thyroid Carcinoma by Regulating the MAPK/ERK Signaling Pathway.
    Hong S; Yu S; Li J; Yin Y; Liu Y; Zhang Q; Guan H; Li Y; Xiao H
    Thyroid; 2016 Dec; 26(12):1733-1743. PubMed ID: 27717302
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long noncoding RNA cancer susceptibility candidate 2 suppresses papillary thyroid carcinoma growth by inactivating the AKT/ERK1/2 signaling pathway.
    Huang F; Zhang Q; Chen W; Zhang H; Lu G; Chen J; Qiu C
    J Cell Biochem; 2019 Jun; 120(6):10380-10390. PubMed ID: 30609134
    [TBL] [Abstract][Full Text] [Related]  

  • 8. STAT1-induced upregulation of lncRNA LINP1 promotes cell proliferation and inhibits apoptosis via AMPK signaling pathway in papillary thyroid cancer.
    Li HP; Yang TZ; Wei L; Ge YF; Meng QS
    Eur Rev Med Pharmacol Sci; 2020 Sep; 24(17):8911-8917. PubMed ID: 32964981
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MicroRNA-486 inhibits cell proliferation, invasion and migration via down-regulating the TENM1 expressions and affecting ERK and Akt signaling pathways and epithelial-to-mesenchymal transition in papillary thyroid carcinoma.
    Sun YH; Liu ZF; Yang BB; Yu B
    Eur Rev Med Pharmacol Sci; 2019 Oct; 23(19):8429-8439. PubMed ID: 31646573
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ropivacaine inhibits proliferation, invasion, migration and promotes apoptosis of papillary thyroid cancer cells via regulating ITGA2 expression.
    Qin A; Liu Q; Wang J
    Drug Dev Res; 2020 Sep; 81(6):700-707. PubMed ID: 32314406
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ciRS-7 Promotes the Proliferation and Migration of Papillary Thyroid Cancer by Negatively Regulating the miR-7/Epidermal Growth Factor Receptor Axis.
    Han JY; Guo S; Wei N; Xue R; Li W; Dong G; Li J; Tian X; Chen C; Qiu S; Wang T; Xiao Q; Liu C; Xu J; Chen KS
    Biomed Res Int; 2020; 2020():9875636. PubMed ID: 32685551
    [TBL] [Abstract][Full Text] [Related]  

  • 12. FBXO2 promotes the progression of papillary thyroid carcinoma through the p53 pathway.
    Guo W; Ren Y; Qiu X
    Sci Rep; 2024 Sep; 14(1):22574. PubMed ID: 39343799
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Overexpression of long noncoding RNA SLC26A4-AS1 inhibits the epithelial-mesenchymal transition via the MAPK pathway in papillary thyroid carcinoma.
    Wang DP; Tang XZ; Liang QK; Zeng XJ; Yang JB; Xu J
    J Cell Physiol; 2020 Mar; 235(3):2403-2413. PubMed ID: 31556116
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Decreased expression of annexin A10 in gastric cancer and its overexpression in tumor cell growth suppression.
    Kim JK; Kim PJ; Jung KH; Noh JH; Eun JW; Bae HJ; Xie HJ; Shan JM; Ping WY; Park WS; Lee JY; Nam SW
    Oncol Rep; 2010 Sep; 24(3):607-12. PubMed ID: 20664964
    [TBL] [Abstract][Full Text] [Related]  

  • 15. miRNA-21 promotes cell proliferation and invasion via VHL/PI3K/AKT in papillary thyroid carcinoma.
    Zang C; Sun J; Liu W; Chu C; Jiang L; Ge R
    Hum Cell; 2019 Oct; 32(4):428-436. PubMed ID: 31161410
    [TBL] [Abstract][Full Text] [Related]  

  • 16. IL-34 is a potential biomarker for the treatment of papillary thyroid cancer.
    Zhang P; Zhang H; Dong W; Wang Z; Qin Y; Wu C; Dong Q
    J Clin Lab Anal; 2020 Aug; 34(8):e23335. PubMed ID: 32573824
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MiR-296-5p suppresses papillary thyroid carcinoma cell growth via targeting PLK1.
    Zhou SL; Tang QL; Zhou SX; Ren RZ
    Eur Rev Med Pharmacol Sci; 2019 Mar; 23(5):2084-2091. PubMed ID: 30915753
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Annexin A10 is a novel prognostic biomarker of papillary thyroid cancer.
    Liu X; Yang M; Guo Y; Lu X
    Ir J Med Sci; 2021 Feb; 190(1):59-65. PubMed ID: 32451762
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Yes-associated protein 1 promotes papillary thyroid cancer cell proliferation by activating the ERK/MAPK signaling pathway.
    Liao T; Wen D; Ma B; Hu JQ; Qu N; Shi RL; Liu L; Guan Q; Li DS; Ji QH
    Oncotarget; 2017 Feb; 8(7):11719-11728. PubMed ID: 28036290
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Suppression of long noncoding RNA LINC00324 restricts cell proliferation and invasion of papillary thyroid carcinoma through downregulation of TRIM29 via upregulating microRNA-195-5p.
    Xu J; Li Z; Su Q; Zhao J; Ma J
    Aging (Albany NY); 2020 Dec; 12(24):26000-26011. PubMed ID: 33318312
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.